The report on the Global Plasma Therapy Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of a comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Major Drivers
- Rising incidences of sports injuries
- Increase in the number of androgenic alopecia patients worldwide
- Growing use of platelet-rich plasma in various therapeutic areas
- Prevalence of arthritis
|
Major Restraints
- Lack of Reimbursement Policies
- Varying Prices of Plasma Therapy
|
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
The report classifies the market into different segments based on type, sources, application and end user. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
Geographical Leader
|
Leading Segment
- By Type - Pure PRP
- By Sources - Autologous
- By Application - Dermatology
- By End User - Hospitals & Clinics
|
|
|
The report also covers the complete competitive landscape of the global Plasma Therapy market with company profiles of key players such as:
- Biolife Plasma Services
- Cambryn Biologics LLC
- Biotest
- CSL Ltd.
- Grifols International S.A.
- Kedrion S.P.A.
- LFB SA
- Bio Product Laboratory Ltd. (BPL)
- China Biologic Products, Inc.
- Octapharma AG
A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
SEGMENTATIONS IN THE REPORT:
By Type:
- Pure PRP
- Leukocyte-Rich PRP
- Pure Platelet-Rich Fibrin
- Leukocyte-Rich Fibrin
By Source:
By Applications:
- Orthopedic
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
- Dermatology
- Androgenic Alopecia
- Plastic Surgery
- Cardiac Muscle Injury
- Dental
- Nerve Injury
- Others
By End User:
- Hospitals & Clinics
- Research Institutes
By Geography:
- North America
- Europe
- Asia Pacific
- Rest of the World
The Global Plasma Therapy Market has been exhibited in detail in the following chapters -
Chapter 1 Plasma Therapy Market Preface
Chapter 2 Executive Summary
Chapter 3 Plasma Therapy Industry Analysis
Chapter 4 Plasma Therapy Market Value Chain Analysis
Chapter 5 Plasma Therapy Market Analysis By Type
Chapter 6 Plasma Therapy Market Analysis By Source
Chapter 7 Plasma Therapy Market Analysis By Applications
Chapter 8 Plasma Therapy Market Analysis By End User
Chapter 9 Plasma Therapy Market Analysis By Geography
Chapter 10 Competitive Landscape Of Plasma Therapy Companies
Chapter 11 Company Profiles Of Plasma Therapy Industry
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.